hotspot -WSS

hotspot

author：comprehensive 2025-09-30 14:09:31 - browse：15

This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug. — Novo Nordisk via AP

PHILADELPHIA — Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss.

The company in August had announced that in this trial, called Select, Wegovy reduced the overall rate of major heart problems — heart attacks, stroke, or cardiovascular-related death — by 20%. That finding, which was the primary outcome the trial set out to study, was stronger than many were expecting and led Novo’s stock to surge.

But details of the study, including risk reductions for each specific heart complication, were not released until Saturday, when they were presented here — before a standing-room only crowd — as the first major session of the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Alabama hospital puts IVF treatments on hold

hotspot

WSS

Laying a path for careers in science

CDC panel: People 65 and older should get a Covid spring booster shot

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

5 ways to address the shortage of health care workers

New documents shed light on MD Anderson Cancer Institute feud

Wikipedia

hotspot

focus

Heart attack and stroke risk calculators need revising

In utero gene editing: an explainer

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Children’s Hospital revives plan for pedestrian bridge

Hepatitis C has a cure — but many Americans still lack access to it

A solution to the after

As demand for Covid shots wanes, Moderna seeks its next success

A new nitrogen execution bill also undermines medical licensing

Apple is now the first public company to be valued at $3 trillion

Change Healthcare cyberattack shows risk of industry consolidation

focus

5 ways to address the shortage of health care workers

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

Alabama hospital puts IVF treatments on hold

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

STAT readers on older presidents, polypills, Medicare, and more

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

knowledge

focus

hotspot

knowledge